Angiogenesis pioneer dies

Article

Judah Folkman, MD, the pioneer of angiogenesis research, died on January 15th 2008.

Judah Folkman, MD, the pioneer of angiogenesis research, died on January 15th 2008.

Dr Folkman was the 2006 recipient of the Helen Keller Prize for Vision Research. His 1971 hypothesis, that solid tumours are angiogenesis-dependent, led researchers to the first angiogenic inhibitor for age-related macular degeneration (AMD), laying the groundwork for drugs such as Lucentis and Macugen.

Thanks to Dr Folkman, ten new cancer drugs are on the market and people who might otherwise be blind have been given a lifeline.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.